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Abstract: A highly pertinent cause of hepatic disfunction and metabolic disorders such as type 2
diabetes are persistent organic pollutants, namely organochlorine (OC) pesticide metabolites
such as trans-nonachlor. Several studies have found positive correlations with OC pesticides and
the development of the hepatic component of metabolic syndrome: non-alcoholic fatty liver
disease (NAFLD), also known as hepatic steatosis. This condition is characterized by the
accumulation of lipids within liver cells. Work in the Howell Lab at Mississippi State
University’s College of Veterinary Medicine explored the cellular mechanisms behind this
association in parallel studies investigating the effects of the organochlorine pesticide, transnonachlor, on hepatic lipid metabolism in two different cell types: immortalized rat hepatoma
(McA) cells and rat primary hepatocytes. The purpose of this study was to compare the results
from these two aforementioned studies, highlighting similarities in the results while also
discussing potential reasons for differences. The following results were the same across both cell
types following exposure to trans-nonachlor: intracellular lipid accumulation increased, de novo
lipogenesis increased, and oxidative stress and fatty acid uptake were unchanged. Fatty acid
oxidation increased in McA cells but decreased in primary hepatocytes. The results for
VLDL/triglyceride secretion were inconclusive. Taken together, the results indicate that transnonachlor promotes intracellular neutral lipid accumulation primarily via increased de novo
lipogenesis, with decreased fatty acid oxidation as another potential contributor.
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1. Introduction
Before any particular pesticide-induced alterations in normal metabolic processes can be
discussed, it is important to first have a general understanding of normal hepatic lipid
metabolism. The liver is the largest organ in the human body, accounting for about 2% of body
weight. Fat can either be stored or mobilized for energy. The storage form of fat is triglyceride,
which consists of three fatty acid chains attached to a glycerol backbone. The mobilized form of
fat is fatty acid. While adipose tissue is the main storage site for fat, the liver is not a fat storage
depot; in fact, it normally harbors very low levels of triglycerides. The liver is a main site of fat
metabolism, for which it has three main functions: breakdown of fatty acids for energy, synthesis
of fat from carbs and proteins, and synthesis of cholesterol, phospholipids, and lipoproteins.
When the body needs energy, triglycerides are mobilized from adipose tissue, transported as free
fatty acids in the blood, and then taken up by target organs, where fat is either metabolized for
energy production or stored as triglycerides. Fats, carbohydrates, and proteins that are consumed
can also be converted to fat in the liver and then sent off to be stored in adipose tissue. The liver
also manufactures lipoproteins, which serve as the carriers of lipids as they pass through the
bloodstream.1
In certain cases, the normal physiological state of the liver can be adversely affected.
Metabolic syndrome was defined by the World Health Organization in 1999 as a pathological
manifestation of metabolic dysfunction characterized by several risk factors, including
abdominal obesity, insulin resistance, hypertension, and hyperlipidemia. Metabolic syndrome is
not itself a disease, but rather a collection of these risk factors.2 As the liver is a primary organ
involved in systemic metabolism, its normal functions are adversely affected as part of the
syndrome’s pathogenesis. Non-alcoholic fatty liver disease (NAFLD), also known as hepatic
1

steatosis, is heavily interconnected with the risk factors of metabolic syndrome and is thus
considered to be the “hepatic component” of the condition and related conditions such as type 2
diabetes (T2D).3 NAFLD is the most common cause of liver disease in industrialized countries
such as the U.S. It is typically associated with obesity and T2D.4 A strong correlation exists
between NAFLD and diabetes: someone with NAFLD has 5x the risk of developing the latter
disease.5 NAFLD is characterized by excess fat accumulation in liver cells. In other words, there
is neutral lipid accumulation (primarily as triglyceride) in hepatocytes. Lipids can accumulate
within hepatocytes for several reasons, such as increased fatty acid uptake, increased de novo
lipogenesis (DNL), decreased fatty acid oxidation, or overwhelmed very low density lipoprotein
(VLDL) secretion.6 As lipid accumulation leads to liver inflammation (hepatitis), the condition
progresses to non-alcoholic steatohepatitis (NASH), a more severe form of NAFLD. Liver
inflammation destroys parenchymal cells, which are replaced with fibrous scar tissue (fibrosis)
that contracts around blood vessels, impeding blood flow. Fibrosis of the liver is known as
cirrhosis.4 The subsequent damage to the liver’s hepatocytes is detrimental to its function.
A potential cause of hepatic disfunction and metabolic disorders such as T2D is exposure
to persistent organic pollutants (POPs), such as organochlorine pesticide metabolites. POPs,
which are lipophilic and hydrophobic, accumulate in the body’s fatty tissues and reside there for
many years because they are resistant to metabolic degradation.7 Epidemiological studies have
shown strong positive correlations with T2D and elevated concentrations of POPs, such as OC
pesticides, in the blood.8,9 In vivo studies in rodents show that chronic exposure to a mixture of
POPs, including OC pesticides, via a diet high in fats promotes T2D and NAFLD. POPs in diets
with fats derived from sources like farmed fatty fish, dairy products, and meat are of particular
interest because animal products are one of the main sources of POP exposure in people.7,10
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Studies in male C57BL/6H mice indicate that both subacute and chronic exposure to the
organochlorine pesticide metabolite dichlorodiphenyldichloroethylene (DDE) promotes fasting
hyperglycemia, a physiological alteration associated with changes in glucose homeostasis in
T2D, without concurrent insulin resistance.11,12 In the ob/ob mouse, a genetic model of obesity
and T2D, exposure to OC pesticides has been shown to promote hepatic steatosis.13 The Howell
Lab at Mississippi State University’s College of Veterinary Medicine explored the cellular
mechanisms behind this association in parallel studies investigating the effects of the
organochlorine pesticide, trans-nonachlor, on hepatic lipid metabolism in two different cell
types.14,15
Two different cell types were used as models to answer these questions: McArdleRH7777 (McA) rat hepatoma cells, and rat primary hepatocytes. The key difference between
these cell lines is that McA cells, which are immortalized, replicate indefinitely in culture,
whereas primary hepatocytes do not multiply once cultured following harvest. Frozen McA cell
stocks were obtained from a private company (American Type Culture Collection; ATCC), while
rat primary hepatocytes were surgically harvested from rats and perfused on-site, then
immediately plated without ever being frozen. McAs are good models for studying NAFLD for
several reasons, one of which being that they can be made steatotic when exogenous fatty acids
are introduced to the media. They also secrete lipoproteins like VLDL and HDL in a way that’s
similar to primary hepatocytes.16 In addition, secretion of ApoB100 protein for VLDL is
suppressed by insulin in McA cells via a process similar to rat primary hepatocytes.17 Whereas
most immortalized hepatoma cell lines express Srebp-1a, McA cells express insulin-sensitive
lipogenic mediator sterol response element binding protein-1c (Srebp-1c), which is the same type
carried by primary hepatocytes.18 Srebp is the master transcriptional regulator for the lipogenic
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gene cascade. For example, the presence of glucose stimulates insulin secretion, which in turn
promotes expression of Srebp1 leading to increased de novo lipogenesis.19 But McAs do have
major drawbacks, including increased fatty acid uptake and fatty acid oxidation compared to
primary hepatocytes.20 Furthermore, in serum-rich culture conditions, McA cells develop insulin
resistance and subsequently secrete more ApoB and VLDL.21 Differences in serum used in the
two cell types’ culture media may also potentially cause differences in experimental results.16
The initial set of experiments was carried out on McA cells, as they are more cost effective and
easier to work with than primary hepatocytes. Because primary cells are a superior model, the
same set of experiments was performed on those next to strengthen the validity of the results.
The purpose of this study is to compare the results from these two aforementioned studies,
highlighting similarities in the results while also discussing potential reasons for differences.

4

2. Methods
2.1 Reagents
McA rat hepatoma cells were purchased from ATCC. Their normal growth media consisted of
high-glucose DMEM, 20% Fetal Bovine Serum (FBS), sodium pyruvate, glutamine, penicillin,
and streptomycin. Normal growth media for primary hepatocytes was RPMI-1640 supplemented
with fatty acid-free bovine serum albumin (BSA), sodium pyruvate, glutamine, penicillin,
streptomycin, and insulin. Trans-nonachlor was purchased from Accu-Standard. Oleic acid,
palmitic acid, Oil Red O stain, and Janus Green stain were obtained from Sigma Aldrich.
Pesticide metabolites were put in solution with the solvent dimethylsulfoxide (DMSO) for a final
DMSO concentration of 0.025%. BODIPY-FA for fatty acid uptake experiments was obtained
from Life Technologies. 14C-acetate for DNL experiments was obtained from Perkin Elmer. βhydroxybutyrate (β-HB), glutathione, TBARS, and triglyceride assay kits were obtained from
Cayman Chemical.
2.2 Primary hepatocyte isolation and culture
Livers were surgically harvested from rats and then perfused with collagenase solution. Cell
suspensions were filtered through 100 micron, then 70 micron filters and centrifuged to purify
the homogenate. Cell concentration and viability via trypan blue exclusion were measured via
hemocytometer. Cell suspensions with 75% viability or greater were subsequently plated at a
concentration of 1 × 106 cells/mL on cell culture plates coated with rat tail collagen to help with
cell adherence. They were left to sit in normal growth media for 3-4 h to allow for sufficient cell
attachment. Adhered cells were washed with PBS and then subjected to various experimental
protocols.
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2.3 Intracellular lipid accumulation
Both cell types were exposed to trans-nonachlor in normal growth media to determine its effects
on intracellular neutral lipid accumulation. Cells were exposed to vehicle (dimethylsulfoxide,
DMSO, 0.025%) or various concentrations of OC pesticide (0.02, 0.2, 2.0, 20, or 80 µM). In all
assays tested, results from no-vehicle controls were not significantly different than vehicle
treated cells, suggesting that the DMSO vehicle itself does not adversely affect metabolic activity
of the cells. McA cells and primary hepatocytes were exposed to trans-nonachlor for 24 h.
Afterwards, cells were washed with PBS and underwent Oil Red O staining to measure
intracellular neutral lipid accumulation. A commercially-available triglyceride assay (Cayman
Chemical) was used to measure intracellular triglyceride levels to confirm that most of the
intracellular neutral lipid accumulation was composed of triglycerides.
2.4 Oil red O staining
Oil Red O stain selectively dyes intracellular neutral lipids, mainly triglyceride and cholesterol
ester. Cells were stained with Oil Red O for 15 min at room temperature. Then, the stain was
washed off with deionized water so that any remaining stain was present intracellularly. The
cells were then allowed to air dry overnight. Intracellular stain was extracted with 100%
isopropanol and the absorbance at 520 nm was measured with a cell plate reader. The
concentration of Oil Red O stain is proportional to the concentration of intracellular neutral
lipids. To normalize for cell number, cells were then stained with Janus Green for 5 min. This
stain was extracted with 0.5 N HCl and absorbance was measured at 595 nm using the same plate
reader. The concentration of Janus Green stain is proportional to the cell number. Final data were
obtained by dividing Oil Red O absorbance by Janus Green absorbance to calculate the
intracellular neutral lipid accumulation per cell concentration.
6

2.5 Fatty acid uptake
Fatty acid uptake assay with Bodipy-labeled fatty acid markers offered a superior method of
measuring fatty acid uptake following free fatty acid induced neutral lipid accumulation in the
McA cells. The extent to which trans-nonachlor exposure induced fatty acid uptake was
determined in both McA cells and primary hepatocytes using Bodipy-labeled 4,4-difluoro-5methyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoic acid (BODIPY 500/510 C12; BODIPY-FA;
Molecular Probes). Bodipy is a fluorophore, a fluorescent chemical that re-emits light upon
excitation, while dodecanoic acid is a 12-carbon fatty acid commonly used to track fatty acid
flux. Cells were exposed to either vehicle (DMSO 0.025%) or trans-nonachlor (20 µM in McA;
0.2, 2, or 20 µM in primary hepatocytes) for 24 h. Following exposure, cells were washed with
PBS and placed in their respective serum free medias (DMEM for McA; RPMI 1640 for primary
hepatocytes) with BSA, then exposed to Bodipy-labeled dodecanoic acid for 1 min and 60 min.
Fatty acid uptake occurs through multiple mechanisms, including rapid transporter mediated
uptake and diffusion. The 1 min exposure was performed to measure rapid transporter uptake,
and the 60 min exposure was performed to measure the combination effect of rapid transporter
uptake and diffusion as well as the net effect of uptake and breakdown during that time period.
Following Bodipy-labeled dodecanoic acid exposure, cells were washed with PBS and
homogenized in sodium dodecyl sulfate (SDS). Subsequently obtained fluorescence intensity of
the cell homogenate was a proportional measure of Bodipy, and thus fatty acid, uptake by the
cells. Protein concentration of cell homogenates was determined using a Bradford assay. Data
was expressed as the fluorescence per unit protein concentration, or RFU per µg protein.

7

2.6 Fatty Acid Oxidation
Fatty acid oxidation is essentially the breakdown of fat into a form that can be used for energy.
In the liver, fatty acids are oxidized into a two-carbon compound called acetyl-CoA. This can be
used to make ATP, an energy molecule, or make ketones such as β-hydroxybutyrate. In
experimental applications, the levels of cellular β-hydroxybutyrate have been widely used as an
index of hepatic fatty acid oxidation. Both cell types were treated with vehicle (DMSO 0.025%)
or trans-nonachlor (20 µM in McAs; 0.2 and 20 µM in primary hepatocytes) for 24 h in serumfree media, then either 400 µM OA or 0.5% BSA was added for the last 8 h. Following exposure,
levels of β-hydroxybutyrate were measured via manufacturer assay (Cayman Chemical).
2.7 VLDL/Triglyceride Secretion
Both cell types were treated using the exposure procedure outlined in Section 2.6. Following
this, the triglycerides were extracted. 500 µl of media from the cell culture was extracted using
the Folch method and the organic phase was dried under a stream of nitrogen gas. The resulting
dried lipid layer was resuspended in 100% methanol and these extracted triglycerides were
quantified using a colorimetric triglyceride assay (Cayman Chemical).
2.8 De Novo Lipogenesis
14

C-acetate was introduced into the cells to measure de novo lipogenesis. By radiolabeling the

acetate with radioactive 14C, it is possible to track the production of new fatty acids, specifically
de novo lipogenesis. Both cell types were exposed to vehicle (DMSO 0.025%) or transnonachlor (20 µM in McAs; 0.2, 2, and 20 µM in primary hepatocytes) in serum free, fatty acid
free media containing 0.5% BSA. In the last 8 h of exposure, the cells were stimulated with
insulin (100 nM). Following exposure, 14C-acetate was added to the cells and incubated for 3 h.
8

Then, the cells were washed with, and resuspended in, PBS. The lipid portion of the cell
suspension was extracted in either 3:2 hexane:isopropanol (primary hepatocytes) or 2:1
chloroform:methanol (McAs), then centrifuged to separate the organic (cells and lipids) and
aqueous phases. 14C-acetate that was not taken up by the cells for de novo lipogenesis was in the
aqueous phase, whereas the 14C-acetate that was used for de novo lipogenesis was present in the
organic phase. The radioactivity of organic phase was quantified by liquid scintillation counting.
2.9 Oxidative stress (Lipid peroxidation/cellular glutathione)
Lipid peroxidation is an index of oxidative stress levels throughout the cell. Oxidative stress is
free radical formation within the cell i.e. free oxygen. If the levels of free radicals get too high,
these reactive oxygen species begin binding to lipids and proteins to create adducts, which cause
cell damage. Cells normally employ anti-oxidant mechanisms to effectively dispose of these free
radicals before they form adducts. However, if there are simply too many free radicals and
adducts to break down, then the cell will undergo apoptosis, essentially a self-destructive
process. Environmental toxins and exposure to pesticides can induce the production of reactive
oxygen species. Malondialdehyde (MDA) is a free radical, specifically an aldehyde formed as a
product during lipid peroxidation. It is widely used as a biomarker for lipid peroxidation of fatty
acids and it reacts well with thiobarbituric acid, the main chemical constituent of peroxidation
assays. Glutathione is the major antioxidant in most cells. It catalyzes the reduction of peroxides
into water and alcohol for filtration and excretion from the body.22 If trans-nonachlor causes
oxidative stress on hepatocytes, this could be a potential factor that explains this pesticide’s
induction of intracellular neutral lipid accumulation. Both McA cells and primary hepatocytes
were exposed to vehicle (DMSO 0.025%) or trans-nonachlor (20 µM in McAs; 0.2 and 20 µM in
primary hepatocytes). Thiobarbituric acid reactive substances (TBARS) assay was performed to
9

quantify cellular levels of MDA and another assay was used to determine levels of glutathione
(Cayman Chemical).
2.10 SDS-PAGE and Western Blot
SDS-PAGE and Western Blot were used to measure quantities of several different proteins in the
cells. Fatty acid synthase (FAS), ApoB, and β-actin were measured in both cell types. β-actin is a
cytoskeletal protein. As a housekeeping protein, it was used to normalize the values of the other
proteins that were measured. McA cells were exposed to trans-nonachlor (0 and 20 µM) for 24 h
in serum-free media with fatty acid free BSA. For the last 8 h, they were treated with OA (400
µM) and then whole cell lysates were made. Primary hepatocytes were exposed for DNL or
VLDL/triglyceride secretion and then cell homogenates were made. For both cell types, cellular
proteins were separated from the cell lysates by SDS-PAGE, transferred to PVDF membranes,
and then underwent Western Blot procedure. Proteins were pictured with chemiluminescence
and digital images were recorded using Bio-Rad. Band densities were measured with ImageJ
software. Data are presented as a normalized ratio of FAS or ApoB integrated densities to β-actin
integrated density.
2.11 Statistical Analysis
Data are expressed as the mean ± the standard error of the mean (SEM). Each individual
animal’s duplicate measurements were averaged, with the average subsequently treated as the
individual animal’s final value. For experiments with one independent treatment but three or
more groups, such as concentration response studies, data were analyzed using a one-way
analysis of variance (ANOVA) along with a Tukey’s post hoc test (SigmaPlot 12.5). For
experiments with only two groups, data were analyzed using a Student’s t-test in order to
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compare results between groups. A two-way ANOVA with a Tukey’s post hoc test was
performed for experiments with two independent treatment groups, such as trans-nonachlor with
or without insulin stimulation. The threshold for statistical significance was set as P ≤ .05.
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3. Results
3.1 Trans-nonachlor exposure significantly increases intracellular lipid accumulation in McA
cells and primary hepatocytes
Both McA cells and primary hepatocytes were initially exposed to trans-nonachlor (20 and 80
µM) in normal growth media for 24 h to quantify levels of intracellular neutral lipid
accumulation, the hallmark of hepatic steatosis. In both McA cells and primary hepatocytes,
trans-nonachlor exposure significantly increased intracellular neutral lipid accumulation. In both
cell types, exposure to both concentrations (20 and 80 µM) of trans-nonachlor for 24 h caused
significant increases in neutral lipid accumulation compared to vehicle. McA cells exposed to the
lower trans-nonachlor concentration (20 μM) showed increased staining of neutral lipids by 61%
compared to vehicle. The higher concentration (80 μM) increased staining of neutral lipids by
78% compared to vehicle. In primary hepatocytes, the lower trans-nonachlor concentration (20
µM) increased neutral lipid staining by 37% compared to vehicle, while the higher concentration
(80 µM) increased staining by 41% compared to vehicle. In both cell types, both the higher and
lower concentrations of trans-nonachlor had a similarly-sized effect on neutral lipid
accumulation. There was no significant difference between their effects, which suggests that
after a certain concentration, the “steatotic effect” levels out.
3.2 The trans-nonachlor induced neutral lipid accumulation is mainly due to build-up of
triglycerides
To prove that the staining results were, in fact, due to intracellular accumulation of triglycerides
cellular triglyceride levels were also measured. In both cell types, there was a positive
association found between 24 h trans-nonachlor exposure (20 µM) and increased cellular
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triglyceride concentrations compared to vehicle. In McA cells, there was a significant, 71%
increase in triglyceride levels following trans-nonachlor exposure (20 μM) compared to vehicle.
Primary hepatocytes exposed to the metabolite (20 μM) showed a significant, 13% increase in
triglyceride levels compared to vehicle. These data indicate that the Oil Red O results appear to
be due to intracellular accumulation of triglycerides in particular.

Fig. 1. Trans-nonachlor exposure significantly
increases intracellular lipid accumulation in McA
cells. After being exposed for 24 hours, (A.) neutral
lipid accumulation and (B.) cellular triglyceride
levels were measured. Data represent the average ±
SEM of n = 8/group for Oil Red O and n = 5/group
for triglyceride measurement. *P < 0.05 vs. vehicle;
#P < 0.05 vs. 2 μM.

Fig. 2. Trans-nonachlor exposure significantly
increases intracellular lipid accumulation in primary
hepatocytes. After being exposed for 24 hours, (C.)
neutral lipid accumulation and (D.) cellular
triglyceride levels were measured. Data represent the
mean ± SEM for n = 5-6 animals/group for ORO
staining and n = 4 animals/group for triglyceride
measurement. *P ≤ .05 versus vehicle (0 μM).
Micrographs demonstrate Oil Red O staining in
primary hepatocytes treated with (A.) vehicle and
(B.) trans-nonachlor.
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3.3 Fatty acid uptake is not increased in McA cells or primary hepatocytes following transnonachlor exposure
Free fatty acid uptake is a major contributor to the development of hepatic steatosis. The
experiment investigated the effects of trans-nonachlor exposure on Bodipy labeled dodecanoic
acid. At 1 min following addition of the Bodipy labeled dodecanoic acid, neither McA cells nor
primary hepatocytes exposed to trans-nonachlor (20 µM in McA; 0.2, 2, or 20 µM in primary
hepatocytes) for 24 h had significantly altered free fatty acid uptake. At 60 min following
addition of the Bodipy labeled dodecanoic acid, treated McA cells did show a significant
increase in accumulation of free fatty acid to vehicle-treated cells. However, treated primary
hepatocytes did not have a significant increase at this 60 min timepoint. In McA cells, it appears
that exposure to trans-nonachlor does not cause direct fatty acid uptake by rapid transporter
proteins but does cause increased fatty acid accumulation overall. In primary hepatocytes,
exposure to trans-nonachlor does not increase fatty acid uptake or accumulation.

Fig. 3. Fatty acid uptake (1 min) is not
increased in McA cells, however there is a
significant increase in free fatty acid
accumulation (60 min). *P < 0.05 vs. vehicle
@ 1 min and #P < 0.05 vs. vehicle @ 60 min.

Fig. 4. Neither fatty acid uptake (1 min) nor
fatty acid accumulation (60 min) is
significantly increased in primary
hepatocytes. Data represent the mean ± SEM
for 8-9 animals/group.
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3.4 Exposure to trans-nonachlor increases fatty acid oxidation in McA cells and decreases
oxidation in primary hepatocytes
Both cell types were exposed to vehicle and 20 µM trans-nonachlor for 24 h in serum-free media
(BSA) with or without addition of fatty acids (OA) for the last 8 h of incubation. β-HB is a
commonly used indicator of fatty acid oxidation and it was used as such in this experiment. In
McA cells, trans-nonachlor exposure causes increased fatty acid oxidation. As expected, in
vehicle-treated cells, the addition of fatty acids (OA) significantly increased β-HB levels by 41%
compared to BSA-treated vehicle cells. Trans-nonachlor exposure in BSA-treated cells led to a
significant 62% increase in β-HB levels compared to BSA-treated vehicle. Trans-nonachlor
exposure in fatty acid-treated cells significantly increased β-HB levels by 42% compared to
fatty-acid treated vehicle. In a normal physiological state, the presence of increased serum fatty
acids leads to increased fatty acid oxidation to maintain homeostasis. This is what happened in
this case. In primary hepatocytes, trans-nonachlor exposure causes decreased fatty acid oxidation
under both basal and steatotic conditions. Trans-nonachlor (20 µM) significantly decreased both
basal and fatty acid (OA) induced cellular β-HB levels by 42% and 49% compared to vehicle
exposed cells.
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Fig. 6. Fatty acid oxidation is significantly decreased
in primary hepatocytes following trans-nonachlor
exposure (0.2 and 20 µM) for 24 h in serum free
media with or without OA for the final 8 h. Cellular
β-HB levels were determined as an index of fatty
acid oxidation. Data represent the mean ± SEM of n
= 4-6 animals/group. *P ≤ .05 versus matching
trans-nonachlor concentration without OA; #P ≤ .05
versus vehicle without OA; &P ≤ .05 versus vehicle
and trans-nonachlor (0.2 μM) with OA.

Fig. 5. Fatty acid oxidation is significantly increased
in McA cells following trans-nonachlor exposure
(20 µM) for 24 h in serum free media with or
without OA for the final 8 h. Cellular β-HB levels
were determined as an index of fatty acid oxidation.
Data represent the mean ± SEM of 5–6/group. *P <
0.05 vs. vehicle + BSA; #P < 0.05 vs. vehicle + OA.

3.5 Trans-nonachlor does not affect VLDL secretion in McA cells, but increases VLDL secretion
in primary hepatocytes under steatotic conditions
Triglyceride secretion was quantified by measuring media levels of triglycerides. Both cell types
were treated using the same culture protocol as outlined in the fatty acid oxidation experiment.
This experiment investigated whether decreased VLDL/triglyceride secretion could be a
contributing factor to the trans-nonachlor-induced increase in intracellular neutral lipid
accumulation. In McAs, trans-nonachlor exposure does not affect triglyceride secretion. No
significant effects were noted as a result of the exposure. In primary hepatocytes, trans-nonachlor
exposure increases triglyceride secretion under steatotic conditions. Under basal conditions
(BSA without added OA), trans-nonachlor exposure (0.2 or 20 µM) did not cause significant
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increases in triglyceride secretion. However, the higher concentration (20 µM) did significantly
increase triglyceride secretion under steatotic (OA-stimulated) conditions by 49% and 40%
compared to BSA-treated and OA-treated vehicle, respectively. The data suggest that transnonachlor does not impair triglyceride secretion under conditions of elevated serum fatty acids.
However, levels of VLDL secretion may not be able to compensate for the increased
accumulation of triglycerides within the hepatocytes.

Fig. 7. VLDL/TG secretion in McA cells is not
affected following trans-nonachlor exposure (20 µM)
for 24 h in serum free media with or without OA for
the final 8 h. Following exposure, media triglyceride
levels were determined. Data represent the mean ±
SEM of n = 6/group.

Fig. 8. VLDL/TG secretion in primary hepatocytes is
significantly increased under steatotic conditions.
Cells were exposed to trans-nonachlor (0.2 and 20
µM) for 24 h in serum free media with or without
OA for the final 8 h. Following exposure, media
triglyceride levels were determined. Data represent
the mean ± SEM of n = 8-9 animals/group. *P ≤ .05
versus vehicle without OA; #P ≤ .05 versus vehicle
with OA.

3.6 Cellular ApoB levels in McA cells are significantly decreased under steatotic conditions
following trans-nonachlor exposure
Cellular production levels of ApoB100 as an indicator of pre-secretion VLDL in hepatocytes
were investigated. In McA cells, trans-nonachlor exposure without additional fatty acid (BSA
17

instead of OA) did not show significant changes in ApoB100 levels compared to vehicle.
However, trans-nonachlor exposed McA cells treated with OA significantly decreased ApoB100
levels by 100% compared to equivalently treated vehicle. While not conclusive, these data
suggest that exposure to trans-nonachlor may potentially have a deleterious effect on cellular
production of ApoB100, and thus on the cells’ ability to secrete VLDL/triglyceride. Transnonachlor exposed primary hepatocytes produced more conclusive results. While the pesticide
did increase cellular levels of ApoB100, these increases were not statistically significant. In
primary hepatocytes, trans-nonachlor exposure does not appear to have an effect on the
production of ApoB protein within the cells.

Fig. 10. Cellular ApoB levels in primary
hepatocytes are not significantly affected by
trans-nonachlor exposure (0.2 and 20 µM).
Cells were exposed for 24 h in serum free
media with or without OA for the final 8 h.
Following exposure, cellular ApoB levels were
determined using Western Blot. Data represent
the mean ± SEM of n = 8-9 animals/group.

Fig. 9. Cellular ApoB levels in McA cells are
significantly decreased under steatotic conditions
following trans-nonachlor exposure (20 µM). Cells
were exposed for 24 h in serum free media with or
without OA for the final 8 h. Following exposure,
cellular ApoB levels were determined using Western
Blot. Data represent the mean ± SEM of n=6/group.
#P < 0.05 vs. vehicle + OA.
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3.7 Trans-nonachlor exposure significantly increases basal de novo lipogenesis in McA cells and
significantly increases insulin-stimulated de novo lipogenesis in primary hepatocytes
DNL is the second largest source of intracellular free fatty acid which can be subsequently taken
up and stored in hepatocytes in the form of triglycerides. Cells were exposed to vehicle and
trans-nonachlor (20 µM) in serum free media with or without insulin stimulation (100 nM)
during the last 8 h of incubation. Following the full 24 h treatment, cells underwent a lipogenic
assay in which 14C-acetate was used as an index of de novo lipogenesis. In McA cells, transnonachlor exposure significantly increases DNL under basal conditions. Insulin stimulation
normally increases DNL, and this trend was seen with the increased DNL in insulin-stimulated
vehicle vs. vehicle without insulin. Trans-nonachlor significantly increased basal, but not insulinstimulated, 14C-acetate integration into hepatocyte lipids by 36% compared to vehicle. These
data indicate that DNL may be a contributing factor to the neutral lipid accumulation resulting
from trans-nonachlor exposure. In primary hepatocytes, trans-nonachlor exposure significantly
increases DNL under conditions of elevated insulin. While trans-nonachlor exposed cells in BSA
showed concentration-dependent increases in DNL compared to vehicle, these were not
statistically significant. However, insulin-stimulated 14C-acetate incorporation was significantly
increased in trans-nonachlor (20 µM) exposed cells by 41% compared to vehicle. In primary
hepatocytes, increased de novo lipogenesis may be a contributing factor towards trans-nonachlor
induced accumulation of intracellular neutral lipids.
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Fig. 11. Trans-nonachlor exposure significantly
increases basal de novo lipogenesis in McA cells.
Cells were exposed to trans-nonachlor (0 or 20 μM)
for 24 h in serum free media with or without insulin
stimulation for the final 8 h then lipogenesis was
determined by 14C-acetate incorporation into total
cellular lipids. Data represent the mean ± SEM of n
= 4/group. *P < 0.05 vs. vehicle without insulin.

Fig. 12. Trans-nonachlor exposure significantly
increases insulin-stimulated de novo lipogenesis
in primary hepatocytes. Cells were exposed to
trans-nonachlor for 24 h in serum free media with
or without insulin stimulation for the final 8 h
then lipogenesis was determined by 14C-acetate
incorporation into total cellular lipids. Data
represent the mean ± SEM for 5 animals/group.
*P ≤ .05 versus matching trans-nonachlor
concentration without insulin; #P ≤ .05 versus
trans-nonachlor (0 μM) with insulin; &P ≤ .05
versus trans-nonachlor (2.0 μM) with insulin.

3.8 Trans-nonachlor significantly increases FAS in primary hepatocytes under basal conditions
The effect of trans-nonachlor on FAS, a major protein involved in the control of lipogenesis, was
investigated using SDS-PAGE and Western Blot techniques. While trans-nonachlor did cause an
increase in FAS protein levels under basal and insulin-stimulated conditions in McA cells, they
were not statistically significant. In primary hepatocytes, trans-nonachlor exposure causes
significant increases in FAS protein levels. As expected, insulin stimulation in vehicle-treated
cells caused a significant increase in FAS levels by 260%. Primary hepatocytes exposed to transnonachlor (20 µM) for 24 hours without insulin stimulation showed a significant 340% increase
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in FAS levels compared to vehicle. Trans-nonachlor exposure with concurrent insulin
stimulation failed to cause a significant increase in FAS.

Fig. 14. Trans-nonachlor exposure significantly
increases FAS in primary hepatocytes. Cells were
exposed for 24 hours with insulin-stimulation for the
final 8 hours then lysates were subjected to western
blotting for FAS expression. Representative western
blots are shown above the graphs. Data represent the
mean ± SEM of n = 6-7 animals/group. *P ≤ .05
versus matching trans-nonachlor concentration
without insulin; #P ≤ .05 versus trans-nonachlor (0
μM) without insulin.

Fig. 13. Trans-nonachlor exposure does not
significantly affect FAS in McA cells. Cells were
exposed for 24 hours with insulin-stimulation for the
final 8 hours then lysates were subjected to western
blotting for FAS expression. Data represent the
mean ± SEM of n = 5/group.

3.9 Trans-nonachlor did not have any effects on oxidative stress in either cell type
Changes in levels of oxidative stress is a known contributor to lipid accumulation in hepatocytes
and subsequent hepatic steatosis. McA cells and primary hepatocytes were exposed to vehicle
and transnonachlor (20 µM in McA; 0.2 and 20 µM in primary hepatocytes) for 24 h and then
MDA levels and glutathione levels were measured. There were no significant changes in either
one. Oxidative stress is unlikely a mechanism through which trans-nonachlor induces neutral
lipid accumulation.
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4. Discussion
4.1 Intracellular neutral lipid accumulation
Intracellular neutral lipid accumulation increased in both cell types when exposed to transnonachlor, under both basal and steatotic conditions. However, the trans-nonachlor (20 µM)
induced lipid accumulation was slightly greater in McA cells than in primary hepatocytes (41%
vs 37%). Additionally, both cell types showed increases in intracellular triglyceride levels
following exposure to trans-nonachlor, suggesting that the accumulated neutral lipid profile is
comprised mainly of triglycerides. Again, however, the results for the triglyceride levels in McA
cells were more extreme than in the primary hepatocytes (71% vs 13%). The fact that McA cells
replicate in culture may have contributed to the greater levels of neutral lipid accumulation
compared to the primary hepatocytes, which do not multiply in culture.
4.2 Fatty acid uptake
The primary source of lipids that accumulate within hepatocytes is free fatty acids that are taken
up into the cell via rapid transporter proteins.15 So, the most obvious explanation for the
accumulation of neutral lipids within hepatocytes would hypothetically be an increase in fatty
acid uptake. However, in both McA cells and primary hepatocytes, trans-nonachlor exposure
does not appear to affect fatty acid uptake. At 1 min, any Bodipy labeled dodecadoic acid that is
taken up by the cells is reflective of direct uptake of free fatty acids by rapid transporter proteins
embedded in the cellular membrane. At this timepoint, neither cell showed increases in labeled
fatty acids, indicating that no fatty acid uptake had taken place via transporter proteins. At 60
min, the concentration of Bodipy labeled dodecadoic acid is indicative of an overall
accumulation of free fatty acids owing to the combination of several mechanisms, including fatty

22

acid uptake, oxidation, and secretion.23 Trans-nonachlor exposed McA cells did show an increase
in labeled fatty acids after 60 min. Thus, although trans-nonachlor causes increased accumulation
of free fatty acids within the cells, this increase is not due to the direct uptake of fatty acids but
may be a product of decreased oxidation or secretion. In primary hepatocytes, trans-nonachlor
had no significant effects on free fatty acid accumulation at 60 min. Since neither cell type
showed trans-nonachlor induced increases in fatty acid uptake, it is unlikely to be a contributing
factor to the intracellular neutral lipid accumulation that has been associated with this pesticide.
4.3 De Novo Lipogenesis
DNL is the second largest source of lipids that accumulate within liver cells. DNL is typically
increased in cases of increased serum insulin concentrations, as is the case with T2D. In both
McA cells and primary hepatocytes, trans-nonachlor caused increased de novo lipogenesis.
However, this increase only occurred in McA cells under basal conditions, while it occurred in
primary hepatocytes only upon stimulation with insulin. The results from the McA cells suggest
that trans-nonachlor increases de novo lipogenesis in normal physiological conditions. The
primary hepatocyte data somewhat contradict these results, as they suggest that trans-nonachlor
exposure increases the formation of new lipids only in states of hyperinsulinemia. However,
McA cells do have a higher intrinsic lipogenic drive because they are immortalized, which may
account for the differing results. Levels of FAS were also measured to track changes in
lipogenesis. FAS is a lipogenic protein and is the key rate limiting enzyme in fatty acid
synthesis.19 An increase in FAS would point towards increased lipogenesis. FAS levels in McA
cells responded to trans-nonachlor exposure under basal and insulin stimulation with general
increases, but these were not statistically significant. However, this particular experiment may
have had different results, had there been more repetitions per group. In primary hepatocytes,
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trans-nonachlor exposure without concurrent insulin stimulation increased FAS levels. However,
exposure with insulin had no significant effects. Together, these results indicate that transnonachlor promotes increased lipogenesis. Despite the differences in the cells’ reactions to transnonachlor regarding insulin stimulation, the general trend in both cell types indicates an increase
in lipogenesis. Thus, de novo lipogenesis appears to be a contributing factor to trans-nonachlor
induced neutral lipid accumulation within liver cells.
4.4 Fatty acid oxidation
Decreased fatty oxidation is another potential explanation for trans-nonachlor’s associated lipid
accumulation. In primary hepatocytes, exposure to the pesticide metabolite significantly
decreased β-HB levels, thereby decreasing fatty acid oxidation, in both basal and fatty acid
stimulated media. The results from the primary hepatocyte experiment indicate that decreased
fatty acid oxidation may contribute to a higher availability of fatty acids for lipid accumulation.
However, in McA cells, exposure to trans-nonachlor caused a significant increase in fatty acid
oxidation under both basal and steatotic (OA-stimulated) conditions. Because trans-nonachlor
did not reduce basal or fatty acid stimulated oxidation, this suggests that oxidation is not a
mechanism through which trans-nonachlor causes neutral lipids to accumulate within McA cells.
One possible explanation for this discrepancy is the fact that McA cells tend to exhibit stronger
fatty acid oxidation activity compared to primary hepatocytes.20 Additionally, since the McA
cells exhibited a larger increase in trans-nonachlor induced intracellular neutral lipid
accumulation and triglyceride levels than primary hepatocytes, this may have indirectly caused a
dramatic increase in fatty acid oxidation. Even if the pesticide did cause a direct reduction in
fatty acid oxidation, it is possible that the extreme upsurge in neutral lipid accumulation caused a
more significant, albeit indirect, escalation of oxidation, thus resulting in a net increase.
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Considering that primary hepatocytes are widely considered to be a better model than McA cells,
it is likely that the decreased fatty acid oxidation seen in this cell type is a more accurate
reflection of general trans-nonachlor induced alterations. Thus, it is likely that decrease fatty acid
oxidation is a contributory mechanism towards the development of hepatic steatosis.
4.5 VLDL/triglyceride secretion
Decreased triglyceride laden VLDL secretion poses another possible explanation for intracellular
neutral lipid accumulation caused by trans-nonachlor exposure. In McA cells, trans-nonachlor
exposure did not affect triglyceride secretion. However, in primary hepatocytes, exposure to the
pesticide metabolite caused increased VLDL secretion under steatotic (increased fatty acid)
conditions. These results cannot be used to conclusively say whether or not sub-optimal VLDL
secretion is a mechanism through which intracellular neutral lipid accumulation occurs. In
addition to secreted triglyceride levels, ApoB was measured as an indicator of pre-secretion
VLDL stability. ApoB100 is the main protein constituent for VLDL particles. Triglycerides are
transported out of the liver in the form of very low density lipoproteins (VLDL). For every
VLDL particle, there is one molecule of ApoB.24 When triglycerides attach themselves to ApoB,
it forms a new VLDL particle. If newly-produced ApoB is not lipidated, the hepatocyte will
break it down, thus controlling VLDL secretion.24 While ApoB levels in primary hepatocytes
were not affected by trans-nonachlor exposure, cellular ApoB levels in McA cells were
significantly decreased following trans-nonachlor exposure under steatotic conditions. In the
McA cells, decreased affinity of triglycerides to ApoB100 proteins indicates impaired VLDL
stability. Research has pointed towards both similarities and differences in ApoB secretory
mechnisms in McA cells vs. primary hepatocytes. Although it has been shown that secretion of
ApoB100 is suppressed by insulin in McA cells via a process similar to rat primary hepatocytes,
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McA cells react differently to serum-rich culture conditions by developing insulin resistance and
subsequently secreting more ApoB and VLDL.17,21 Thus, there may be additional undiscovered
differences regarding ApoB secretion in McA cells that have not yet been brought to light. Given
the lack of available information regarding ApoB secretion in McA cells, again these results
cannot conclusively say whether alterations in ApoB secretion contribute to potentially subsufficient levels of VLDL following trans-nonachlor exposure.
4.6 Oxidative stress
Oxidative stress was investigated as another potential factor in trans-nonachlor induced neutral
lipid accumulation. In both cell types, trans-nonachlor had no effects on lipid peroxidation
(MDA levels) or levels of cellular glutathione, suggesting that oxidative stress is unlikely to be a
mechanism contributing to the intracellular accumulation of lipids.

26

5. Conclusion
The purpose of this study was to elucidate the similarities and differences in the results of
the two parallel studies conducted on immortalized rat hepatoma (McA) cells and rat primary
hepatocytes. These two studies investigated the effects of the organochlorine pesticide
metabolite, trans-nonachlor, on cellular mechanisms governing hepatic lipid metabolism.
Following exposure, both cell types showed significant increases in triglyceride-dominated
intracellular neutral lipid accumulation. These results implicate exposure to trans-nonachlor in
the promotion of non-alcoholic fatty liver disease (also known as hepatic steatosis), the hepatic
component of metabolic syndrome and related conditions such as T2D. From parallel results
seen in both cell types, the most likely contributor to this hepatic steatosis is increased de novo
lipogenesis. Even though fatty acid oxidation was increased in McA cells, it was, in fact,
decreased in primary hepatocytes. Given the fact that the latter cell type is widely considered to
be a more physiologically relevant model, it is likely that decreased fatty acid oxidation may play
a role in the development of fatty liver. Neither cell type had altered oxidative stress or fatty acid
uptake, so it is improbable that these mechanisms are responsible for the hepatic steatosis. The
results for VLDL/triglyceride secretion were unfortunately inconclusive, but sub-optimal VLDL
secretion should not be discounted as a potential reason for the accumulation of lipids within
hepatocytes; further experiments should be conducted to clarify the association.
Over the course of this study, it has become increasingly evident that there is a definite
need for the physiological differences between immortalized rat hepatoma cells and rat primary
hepatocytes to be investigated. While some studies have revealed differences in cellular
mechanisms and genetics, there have been no experiments designed for the sole purpose of
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investigating these contradictions. Such information would greatly benefit all future research
related to pathologies of the liver.
This investigation has brought to light several likely cellular mechanisms by which transnonachlor induces neutral lipid accumulation. However, further studies, particularly those
involving in vivo experiments, are necessary to help clarify how these physiological alterations
are truly manifested in mammals. Most importantly, this study adds to the mounting evidence
implicating organochlorine pesticides in the development of metabolic syndrome in humans, a
connection which is steadily becoming more difficult to refute.
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